“Generalized Pustular Psoriasis Market” has been added to DelveInsight
Generalized Pustular Psoriasis Overview
Generalized Pustular Psoriasis (GPP) is a subtype of pustular psoriasis characterized by painful and occasionally disfiguring cutaneous manifestations with sepsis-like systemic symptoms. Psoriasis is an immune-mediated disease being characterized by red scaly patches on the skin. It is clinically classified into two groups: pustular and non-pustular lesions.
Generalized Pustular Psoriasis Market Insights
The Generalized Pustular Psoriasis market report provides an understanding of the epidemiology and changing market dynamics of Generalized Pustular Psoriasis (GPP) in the seven major pharmaceutical markets for the period 2017–2030
Get a free Generalized Pustular Psoriasis market report sample page- https://www.delveinsight.com/sample-request/generalized-pustular-psoriasis-gpp-market
Generalized Pustular Psoriasis Market: Regions Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Generalized Pustular Psoriasis Market: Symptoms
Generalized pustular psoriasis has been associated with abnormalities in the cytokine (messenger protein) interleukin-36 receptor-antagonist signaling. This is due to recessive IL36RN gene mutations systemic symptoms and systemic upset.
Generalized Pustular Psoriasis Market: Report
Non-pustular psoriasis is further subdivided into Psoriasis vulgaris (early and late onset), Guttate psoriasis, Erythrodermic psoriasis, Palmoplantar psoriasis, Psoriatic arthritis (PsA), and Inverse psoriasis. The Pustular variant of the psoriasis is further subdivided into generalized and localized forms. The generalized form of pustular psoriasis is a potentially life-threatening, multisystemic inflammatory disease characterized by sudden, repeated episodes of high-grade fever, generalized erythematous pustular rashes, painful and occasionally disfiguring cutaneous manifestations with sepsis-like.
Generalized Pustular Psoriasis Treatment
The current therapeutic landscape of GPP in the United States is driven by supportive therapies (topical therapies, systemic therapies, biologics, and phototherapy). In EU-5 countries, for GPP, the market is the same as that of the US, with prescriptions for supportive therapies, due to lack of approved treatment regimens. In contrast to the US and EU-5 countries, the current therapeutic landscape of GPP in Japan is driven by a number of approved therapies, along with supportive treatment regimens.
Generalized Pustular Psoriasis Key Strengths
- 11 Year Forecast
- 7MM Coverage
- Epidemiology Segmentation
- Drugs Uptake
- Highly Analyzed Market
- Key Cross Competition
- Market Size by Country
- Market Size by Therapy
Key companies of the report
- Janssen Pharmaceuticals
- Novartis
- Kyowa Hakko Kirin
- AbbVie/Boehringer Ingelheim
- AbbVie/Eisai
- Eli Lilly & Company
Generalized Pustular Psoriasis Market Size
The dynamics of the GPP market are anticipated to change in the coming years owing to the expected launch of emerging therapies during the forecasted period of 2020–2030. With this, several companies have shifted their focus toward this therapeutic area, and two of the therapies are expected to enter the treatment market of GPP during our forecast period, namely BI 655130 (Boehringer Ingelheim) and Imsidolimab (ANB019) (AnaptysBio).
Table of content
- Key Insights
- Generalized Pustular Psoriasis (GPP): Market Overview at a Glance
- Generalized Pustular Psoriasis (GPP): Disease Background and Overview
- Epidemiology and Patient Population
- United States Epidemiology
- EU5 Epidemiology
- Japan Epidemiology
- Treatment Algorithm, Current Treatment, and Medical Practices
- Proposed Guidelines for the Diagnosis and Treatment of GPP
- Unmet Needs
- Marketed Products
- Emerging Therapies
- GPP: 7MM Market Analysis
- United States: Market Outlook
- EU-5 countries: Market Outlook
- Japan Market Outlook
- Market Drivers
- Market Barriers
- Appendix
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Generalized Pustular Psoriasis Key benefits
- This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving Generalized Pustular Psoriasis market
- Organize sales and marketing efforts by identifying the best opportunities for Generalized Pustular Psoriasis market
- To understand the future market competition in the GPP market.
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving the Generalized Pustular Psoriasis market
- To understand the future market competition in the Generalized Pustular Psoriasis market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Generalized Pustular Psoriasis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Generalized Pustular Psoriasis market
- To understand the future market competition in the Generalized Pustular Psoriasis market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
